FCM
CDLX icon

Frontier Capital Management’s Cardlytics CDLX Stock Holding History

Frontier Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,423
Closed -$895K – 267
2023
Q3 		$895K Sell
5,423
-26,471
-83% -$3.44M 0.01% 258
2023
Q2 		$2.02M Sell
31,894
-327
-1% -$19.8K 0.02% 248
2023
Q1 		$1.09M Sell
32,221
-2,912
-8% -$152K 0.01% 254
2022
Q4 		$2.03M Sell
35,133
-104
-0.3% -$6.42K 0.02% 252
2022
Q3 		$3.31M Buy
35,237
+9,035
+34% +$1.29M 0.04% 251
2022
Q2 		$5.85M Sell
26,202
-753
-3% -$252K 0.07% 236
2022
Q1 		$14.8M Buy
26,955
+1,156
+4% +$699K 0.13% 187
2021
Q4 		$17.1M Sell
25,799
-5,515
-18% -$4.22M 0.13% 187
2021
Q3 		$26.3M Sell
31,314
-11,956
-28% -$12.1M 0.21% 154
2021
Q2 		$54.9M Buy
43,270
+33,398
+338% +$37.7M 0.4% 86
2021
Q1 		$10.8M Sell
9,872
-7,232
-42% -$9.55M 0.08% 219
2020
Q4 		$24.4M Sell
17,104
-18,525
-52% -$19.8M 0.18% 172
2020
Q3 		$25.1M Sell
35,629
-9,429
-21% -$6.86M 0.22% 151
2020
Q2 		$31.5M Sell
45,058
-1,752
-4% -$1.01M 0.28% 132
2020
Q1 		$16.4M Buy
46,810
+13,532
+41% +$9.58M 0.18% 156
2019
Q4 		$20.9M Sell
33,278
-33,168
-50% -$16.2M 0.15% 172
2019
Q3 		$22.3M Sell
66,446
-38,804
-37% -$12.4M 0.17% 161
2019
Q2 		$27.3M Sell
105,250
-57,875
-35% -$11.6M 0.21% 151
2019
Q1 		$27M Buy
163,125
+16,847
+12% +$2.74M 0.19% 163
2018
Q4 		$15.8M Buy
146,278
+75,115
+106% +$12.7M 0.13% 193
2018
Q3 		$17.8M Buy
71,163
+48,404
+213% +$10.4M 0.11% 210
2018
Q2 		$4.95M Buy
22,759
+21,747
+2,149% +$4.03M 0.04% 264
2018
Q1 		$148K Buy
+1,012
New +$171K ﹤0.01% 275

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

Frontier Capital Management's CDLX Position: Q4 2023 in Review

Frontier Capital Management sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 5,423 shares — an estimated $895K sold.

Frontier Capital Management first reported a position in CDLX in Q1 2018 and held it in 23 quarters. The position peaked at $54.9M in Q2 2021. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

  • Frontier Capital Management reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
  • Frontier Capital Management sold 5,423 Cardlytics shares in Q4 2023, an estimated $895K.
  • Frontier Capital Management first reported a position in Cardlytics in Q1 2018 and held it in 23 quarters.
  • Frontier Capital Management's Cardlytics position peaked at $54.9M in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on Frontier Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.